Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nature scenes vs. needles: can a sensory escape calm Kids' blood draws?

NCT ID NCT05494684

NEW Symptom relief Sponsor: University of Oulu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 13, 2026 · Last updated Oct 13, 2026

Summary

Researchers are testing whether a multisensory nature experience, using natural materials and a virtual natural setting, reduces anxiety, fear, and pain in hospitalized children aged 5 to 9 during venous blood sampling. The trial compares this approach with standard care and also measures parents' anxiety and satisfaction, plus how long the blood draw takes. About 106 children with long-term illnesses who have had blood draws before take part, and observers rate the children's anxiety from video.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a multisensory nature-based experience using natural materials and a virtual natural environment
What this could lead to
If it helps, hospitals could offer a low-cost, drug-free way to calm children during blood draws and other needle procedures.
What could go wrong
The trial is small and single-country, so results may not hold for all children or settings. Distraction approaches do not work for every child, and some may still feel fear or pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 106 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 9 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The child is aged between 5 and 9 years old 2. The child has a long-term illness (such as diabetes or rheumatism) 3. The child has previous experience of venous blood sampling 4. The child's level of development is age-appropriate (such as, the child is cared for at home or in day care/day nursery or attends school in the same level as the other children) 5. Child and parent understand and speak the Finnish language Exclusion Criteria: 1. The child has a diagnosis of abnormal neurological development (such as, a child has difficulty understanding spoken language or expressing emotions) 2. The child has chronic pain that has lasted more than 3 months and requires strong painkillers (opiates). 3. The child undergoes an examination or treatment during a check-up at the outpatient clinic that requires medical treatment similar to anesthesia 4. The child is taking a sedative medication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety FEAR Pain Satifaction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Oulu University

    RECRUITING

    Oulu, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.